Prospero Pharmaceuticals Pvt Ltd
About Prospero Pharmaceuticals Pvt Ltd
Data last updated:
Prospero Pharmaceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 11 February 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1983PTC035856. Its GSTIN is 19AABCP4974E1Z8 (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.1 Lakh. It is led by directors Atish Saha and Dipak Kar.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/4 Anandapur Road, Kolkata, West Bengal, India – 700078.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.13 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹5.88 Lakh (net margin 1.9%) and EBITDA of ₹10.7 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh and satisfied charges of ₹5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/4 Anandapur Road, Kolkata, West Bengal, India – 700078
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Prospero Pharmaceuticals Pvt Ltd
The main business activities of Prospero Pharmaceuticals are manufacturing, trade and information and communication. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading and publishing of computer operating systems, system software, application software, games, etc.. 3 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
| J | Information and communication | J2 | Publishing of computer operating systems, system software, application software, games, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prospero Pharmaceuticals Pvt Ltd FY 2025 filings available
Prospero Pharmaceuticals Pvt Ltd reported revenue of ₹3.13 Cr (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Prospero Pharmaceuticals Pvt Ltd
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Prospero Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.88 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prospero Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prospero Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals Pvt Ltd is audited by R.N. BANERJEE for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R.N. BANERJEE | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atish Saha | Director | 10 Oct 2018 | 7 Years 11 Months | Current |
| Dipak Kar | Director | 02 Mar 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Prospero Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Prospero Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2001 | Indian Overseas Bank | ₹5 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Prospero Pharmaceuticals Pvt Ltd
Employment history and EPFO contributions of people linked to Prospero Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231WB1983PTC035856. The current CIN is U24231WB1983PTC035856, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231WB1983PTC035856 | Current |
| L24231WB1983PTC035856 | Previous |
Recent Activity on Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals Pvt Ltd has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Dipak Kar ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Prospero Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prospero Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prospero Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCP4974E1Z8 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prospero Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prospero Pharmaceuticals Pvt Ltd
Prospero Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 11 February 1983 (43+ years old) and is registered under CIN U24231WB1983PTC035856.
Prospero Pharmaceuticals reported revenue of ₹3.13 Cr for FY 2025 (down 11% YoY).
Prospero Pharmaceuticals has 2 current directors:
- Atish Saha - Director
- Dipak Kar - Director
Prospero Pharmaceuticals reported a net profit of ₹5.88 Lakh (net margin 1.9%) and EBITDA of ₹10.7 Lakh (EBITDA margin 3.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Prospero Pharmaceuticals is 18% over three years and 12% over five years. In the latest year (FY 2025) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Prospero Pharmaceuticals is 19AABCP4974E1Z8, registered in West Bengal.
The CIN (Corporate Identification Number) of Prospero Pharmaceuticals is U24231WB1983PTC035856. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prospero Pharmaceuticals was incorporated on 11 February 1983, making it 43+ years old. It is registered with the Registrar of Companies, Kolkata.
Dipak Kar ceased to be Additional Director on 30 Sep 2022. Amit Kumar Ray ceased to be Director on 28 Mar 2022. Dipak Kar was appointed as Director on 02 Mar 2022. Prospero Pharmaceuticals has 6 board changes on record in total.
The registered office of Prospero Pharmaceuticals is at C4 Anandapur Road, Kolkata, West Bengal, India – 700078.